FDA Cites Imaging Drug Web Sites, Draws "Respectful" Disagreement
This article was originally published in The Gray Sheet
Executive Summary
Bracco Diagnostics took down a promotional Web site recently, under protest, to comply with a request from FDA's Division of Drug Marketing, Advertising and Communications that it stop making "false and unsubstantiated claims" for its contrast media agent Isovue (iopamidol-370)
You may also be interested in...
Social Media Promotion Guidance Requested, But Won't Be Out Soon
Medical products companies are asking for more guidance from both FDA and from trade organizations on best practices for Internet marketing and promotion using social media tools
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.